Groundbreaking Phase 3 trial results released on Saturday, February 7, 2026, reveal that a high-dose intensive therapy protocol significantly accelerates recovery for infants who have suffered a perinatal stroke. The study, known as I-ACQUIRE, provides the strongest evidence to date that “more is better” when it comes to early intervention for pediatric hemiparesis.
The data confirms that toddlers receiving the highest concentration of task-oriented therapy achieved functional milestones at a rate nearly double that of those in standard care.
Key Clinical Findings: High-Dose vs. Traditional
The I-ACQUIRE (Intensive Infant Rehabilitation) trial compared two different dosages of a specialized pediatric constraint-induced movement therapy (P-CIMT) against “Usual and Customary Treatment” (U&CT).
The 3.3 Skill Leap: Infants in the high-dose group gained an average of 3.3 new motor skills within six months of treatment. These skills included essential functional movements like reaching, grasping, and bimanual toy manipulation.
The Dosage Factor: The high-dose protocol involved 120 hours of therapy (6 hours/day, 5 days/week for 4 weeks). In contrast, standard community care typically offers only 1–2 hours per week.
Sustained Progress: The motor gains were not just temporary; blinded assessments 6 months post-treatment showed that the high-dose group continued to outpace peers in the moderate-dose and control groups.
How I-ACQUIRE Works
Unlike traditional physical therapy, I-ACQUIRE utilizes a high-intensity “burst” model designed to harness the peak neuroplasticity of the infant brain (ages 8–36 months).
| Feature | High-Dose I-ACQUIRE | Traditional Therapy (U&CT) |
| Daily Intensity | 6 Hours | ~1 Hour (Weekly) |
| Duration | 4 Consecutive Weeks | Ongoing / Intermittent |
| Method | CIMT: Casting the stronger arm to force use of the weaker arm. | General play-based movement. |
| Setting | Home or “homelike” environments for natural learning. | Clinical or outpatient office. |
Why This Matters for 2026
Perinatal arterial stroke is a leading cause of hemiparetic cerebral palsy, affecting roughly 1 in 2,500 live births. For decades, the medical community debated whether intensive therapy was safe or effective for such young patients.
Closing the Gap: Researchers note that the 3.3 skill gain is “clinically transformative,” moving children from dependency to much higher levels of independence in daily activities.
Harnessing Plasticity: The study proves that the infant brain is uniquely “primed” for rewiring if the stimulus is frequent and intense enough.
National Impact: With 15 sites across the United States participating, these results are expected to change the national standard of care, pushing insurance providers to cover high-intensity “burst” rehabilitation for pediatric stroke survivors.
“We are seeing a level of recovery previously thought impossible for this age group. By intervening with high intensity during this critical window, we are effectively changing the trajectory of these children’s lives.” — Lead Investigator, I-ACQUIRE Phase 3 Trial, Feb 2026
